Cryoport continues its expansion in the european market with tec4med lifescience gmbh acquisition

Strategic acquisition strengthens condition monitoring systems and logistics management capabilities for the biopharmaceutical industry throughout cryoport's family of companies nashville, tenn. , nov. 2, 2023 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport" or the "company"), a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences, today announced the acquisition of tec4med lifescience gmbh ("tec4med"), a solution provider and innovation leader in the pharmaceutical supply chain visibility, condition monitoring and temperature-controlled packaging space.
CYRX Ratings Summary
CYRX Quant Ranking